CN1376054A - 含环丙沙星和地塞米松的局部悬浮制剂 - Google Patents

含环丙沙星和地塞米松的局部悬浮制剂 Download PDF

Info

Publication number
CN1376054A
CN1376054A CN 00813262 CN00813262A CN1376054A CN 1376054 A CN1376054 A CN 1376054A CN 00813262 CN00813262 CN 00813262 CN 00813262 A CN00813262 A CN 00813262A CN 1376054 A CN1376054 A CN 1376054A
Authority
CN
China
Prior art keywords
weight
composition
dexamethasone
ciprofloxacin
wt
Prior art date
Application number
CN 00813262
Other languages
English (en)
Chinese (zh)
Other versions
CN1158994C (zh
Inventor
O·N·辛格
H·G·柏翟特
Original Assignee
爱尔康公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US15594299P priority Critical
Application filed by 爱尔康公司 filed Critical 爱尔康公司
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22557406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1376054(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of CN1376054A publication Critical patent/CN1376054A/zh
Application granted granted Critical
Publication of CN1158994C publication Critical patent/CN1158994C/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/912Ophthalmic
CNB008132623A 1999-09-24 2000-08-10 含环丙沙星和地塞米松的局部悬浮制剂 CN1158994C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15594299P true 1999-09-24 1999-09-24

Publications (2)

Publication Number Publication Date
CN1376054A true CN1376054A (zh) 2002-10-23
CN1158994C CN1158994C (zh) 2004-07-28

Family

ID=22557406

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008132623A CN1158994C (zh) 1999-09-24 2000-08-10 含环丙沙星和地塞米松的局部悬浮制剂

Country Status (21)

Country Link
US (2) US6284804B1 (und)
EP (1) EP1214056B1 (und)
JP (2) JP2003510263A (und)
CN (1) CN1158994C (und)
AR (1) AR025661A1 (und)
AT (1) AT252887T (und)
AU (1) AU776609B2 (und)
BR (1) BR0014203A (und)
CA (1) CA2379605C (und)
DE (1) DE60006262T2 (und)
DK (1) DK1214056T3 (und)
ES (1) ES2207549T3 (und)
HK (1) HK1045653A1 (und)
MX (1) MXPA02003130A (und)
PL (1) PL201130B1 (und)
PT (1) PT1214056E (und)
SA (1) SA709B1 (und)
TR (1) TR200200737T2 (und)
TW (1) TWI228423B (und)
WO (1) WO2001022936A1 (und)
ZA (1) ZA200201904B (und)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101317847B (zh) 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
CN101970042A (zh) * 2008-02-25 2011-02-09 眼门药品公司 经由离子电渗法增强递送治疗药物至眼部组织
WO2013084194A1 (en) * 2011-12-09 2013-06-13 Lupin Limited Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents
CN103565816A (zh) * 2012-07-25 2014-02-12 天津金耀集团有限公司 妥布霉素地塞米松滴眼液
CN107970244A (zh) * 2016-10-21 2018-05-01 武汉武药科技有限公司 一种含有环丙沙星和地塞米松的组合物及其制备方法
CN108403700A (zh) * 2018-06-12 2018-08-17 新疆生产建设兵团第师畜牧兽医工作站 一种牛呼吸道疾病治疗用复合注射液

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200200737T2 (tr) * 1999-09-24 2002-08-21 Alcon, Inc. Siproflaksasin ve deksametazon içeren lokal süspansiyon formülasyonları
AU2002216357B2 (en) * 2000-11-15 2006-08-17 Chandavarkar, Mohan A Pharmaceutival preparations comprising corticosteroids and antiinfective agents
KR20040019034A (ko) * 2001-07-06 2004-03-04 수캄포 아게 인터루킨 2 억제제 및 항미생물제를 포함하는 국소 투여용조성물
CA2459930C (en) * 2001-09-21 2009-11-10 Alcon, Inc. Method of treating middle ear infections
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
CA2476410C (en) * 2002-03-01 2013-09-24 Celltech R & D, Inc. Methods to increase or decrease bone density
US7727549B2 (en) * 2002-07-15 2010-06-01 Alcon, Inc. Pharmaceutical compositions for otic use
US20040101506A1 (en) * 2002-11-25 2004-05-27 Fust Charles A. Composition for the prevention and treatment of inflammation of the ear
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
TWI335819B (en) * 2002-12-24 2011-01-11 Alcon Inc Use of oculosurface selective glucocorticoid in the treatment of dry eye
JP2006518769A (ja) * 2003-02-21 2006-08-17 サン・ファーマシューティカル・インダストリーズ・リミテッドSun Pharmaceutical Industries Limited 安定な眼科用組成物
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US20040202687A1 (en) * 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
EP1627637A1 (en) * 2003-05-23 2006-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic solution containing quinolone antimicrobial compound
US8940321B2 (en) * 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
ES2245611B1 (es) * 2004-06-29 2007-03-16 Laboratorio Reig Jofre, S.A. Composicion farmaceutica para uso ototopico.
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US8271101B2 (en) * 2007-08-29 2012-09-18 Advanced Bionics Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead
JP4696251B2 (ja) * 2007-12-28 2011-06-08 防衛省技術研究本部長 多剤耐性緑膿菌の単離方法並びに多剤耐性緑膿菌選択培地の作成方法
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
WO2010004594A1 (en) * 2008-07-08 2010-01-14 S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. Ophthalmic compositions for treating pathologies of the posterior segment of the eye
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
KR20110123789A (ko) * 2009-03-03 2011-11-15 알콘 리서치, 리미티드 리셉터 티로신 키나제 저해(RTKi) 화합물을 눈에 전달하기 위한 약학 조성물
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
EP3508197A1 (en) * 2009-10-21 2019-07-10 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
DK2366408T3 (da) 2010-03-01 2012-10-22 Salvat Lab Sa Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
US8916171B2 (en) 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
ES2658995T3 (es) 2012-12-26 2018-03-13 Otic Pharma Ltd. Composiciones farmacéuticas óticas espumables
JP2016534121A (ja) 2013-08-27 2016-11-04 オトノミ—,インク. 小児の耳の病気の処置
US20150119371A1 (en) * 2013-10-30 2015-04-30 Micro Labs Limited Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
CA2954170A1 (en) * 2014-07-03 2016-01-07 Otonomy, Inc. Sterilization of ciprofloxacin composition
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
ES2111083T3 (es) 1991-09-17 1998-03-01 Alcon Lab Inc Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).
ES2065846B1 (es) * 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
JP3781792B2 (ja) * 1993-12-27 2006-05-31 三菱化学株式会社 ジフルプレドナート含有点眼用懸濁液剤
ES2078175B1 (es) 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5843930A (en) 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
DE19524691A1 (de) 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
KR0155950B1 (ko) 1995-08-16 1998-12-01 김광호 플라즈마 확산 제어 방법 및 그 장치
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
AR020660A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
BR9914158A (pt) 1998-09-30 2001-06-26 Alcon Lab Inc Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
TR200200737T2 (tr) * 1999-09-24 2002-08-21 Alcon, Inc. Siproflaksasin ve deksametazon içeren lokal süspansiyon formülasyonları

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101317847B (zh) 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
CN101970042A (zh) * 2008-02-25 2011-02-09 眼门药品公司 经由离子电渗法增强递送治疗药物至眼部组织
US9149525B2 (en) 2008-02-25 2015-10-06 Eyegate Pharmaceuticals, Inc. Delivery of corticosteroids through iontophoresis
US9820935B2 (en) 2008-02-25 2017-11-21 Eyegate Pharmaceuticals, Inc. Delivery of corticosteroids through iontophoresis
WO2013084194A1 (en) * 2011-12-09 2013-06-13 Lupin Limited Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents
CN103565816A (zh) * 2012-07-25 2014-02-12 天津金耀集团有限公司 妥布霉素地塞米松滴眼液
CN107970244A (zh) * 2016-10-21 2018-05-01 武汉武药科技有限公司 一种含有环丙沙星和地塞米松的组合物及其制备方法
CN108403700A (zh) * 2018-06-12 2018-08-17 新疆生产建设兵团第师畜牧兽医工作站 一种牛呼吸道疾病治疗用复合注射液

Also Published As

Publication number Publication date
PL359623A1 (xx) 2004-08-23
AU776609B2 (en) 2004-09-16
TWI228423B (en) 2005-03-01
WO2001022936A8 (en) 2002-01-24
US20010034339A1 (en) 2001-10-25
AR025661A1 (es) 2002-12-11
SA709B1 (ar) 2006-04-22
CN1158994C (zh) 2004-07-28
DK1214056T3 (da) 2004-02-09
CA2379605C (en) 2007-06-26
PT1214056E (pt) 2004-02-27
CA2379605A1 (en) 2001-04-05
PL201130B1 (xx) 2009-03-31
WO2001022936A1 (en) 2001-04-05
ZA200201904B (en) 2003-05-28
AT252887T (de) 2003-11-15
EP1214056B1 (en) 2003-10-29
DE60006262D1 (de) 2003-12-04
JP2003510263A (ja) 2003-03-18
MXPA02003130A (es) 2004-04-21
HK1045653A1 (en) 2004-01-30
DE60006262T2 (de) 2004-05-13
JP2011032293A (ja) 2011-02-17
US6284804B1 (en) 2001-09-04
ES2207549T3 (es) 2004-06-01
BR0014203A (pt) 2002-05-21
US6359016B2 (en) 2002-03-19
AU7057000A (en) 2001-04-30
EP1214056A1 (en) 2002-06-19
TR200200737T2 (tr) 2002-08-21

Similar Documents

Publication Publication Date Title
EP0711546B1 (en) Ophthalmic solution based on diclofenac and tobramycine and its applications
CN1050514C (zh) 眼用或鼻用抗过敏组合物
DE60204142T2 (de) Zubereitungen mit olopatadin zur topischen anwendung
US4188373A (en) Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
JP5709279B2 (ja) ポビドンヨードを含む眼用組成物
US5414011A (en) Preservative system for ophthalmic formulations
CN1133432C (zh) 含水液体药物组合物
US6166012A (en) Antibiotic compositions and method for using same
ES2316867T3 (es) Uso de rimexolona en el tratamiento del ojo seco.
US5653972A (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US5843930A (en) Method of treating otitis with ciprofloxacin-hydrocortisone suspension
CA2174550C (en) Suspension of loteprednol etabonate
US20140363511A1 (en) Method of treating middle ear infections
US5558876A (en) Topical ophthalmic acidic drug formulations
JP4664499B2 (ja) 共溶媒処方物
AU2004222295A1 (en) Self-emulsifying compositions, methods of use and preparation
FI95773C (fi) Menetelmä vesipitoisen, N-(3,4-dimetoksikinnamoyyli)antraniilihappoa sisältävän farmaseuttisen koostumuksen valmistamiseksi
US20080070908A1 (en) Compositions including antibiotics and methods for using same
US5965549A (en) Ciprofloxacin-hydrocortisone suspension
KR100508227B1 (ko) 로테프레드놀에타보네이트수성현탁액
JPH06239762A (ja) ポリミキシン−トリメトプリム及び抗炎症薬を含有する医薬製剤
US6114319A (en) Compositions containing difluprednate
WO1996003158A1 (en) Use of low molecular weight amino acids in ophthalmic compositions
AU2002216357B2 (en) Pharmaceutival preparations comprising corticosteroids and antiinfective agents
JPH10512265A (ja) 殺菌性/透過性増強タンパク質(bpi)タンパク質産物を含む、改良された治療用組成物

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20191218

Address after: Basel

Patentee after: Novartis Co., Ltd.

Address before: Hananberg, Switzerland

Patentee before: Alcon Company

Effective date of registration: 20191218

Address after: Basel

Patentee after: Novartis Co., Ltd.

Address before: Hananberg, Switzerland

Patentee before: Alcon Company

TR01 Transfer of patent right

Effective date of registration: 20191223

Address after: Fribourg

Patentee after: Alcon Company

Address before: Basel

Patentee before: Novartis Co., Ltd.